|

Cladribine s.c. injection, HCL treatment Clinical Trials

1 actively recruiting trial

Also known as: 2-CdA, Litak(R)

Pipeline

Phase 2/3: 1

Top Sponsors

  • University of Giessen1

Indications

  • Hairy Cell Leukemia1
  • Cancer1

Other1 trial

Therapy Optimisation for the Treatment of Hairy Cell Leukemia
Phase 2/3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.